Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[No title available]
[No authors listed] [No authors listed] PMID: 38579762
Defining and Addressing Research Priorities in Cancer Cachexia through Transdisciplinary Collaboration.
Park MA, Whelan CJ, Ahmed S, Boeringer T, Brown J, Crowder SL, Gage K, Gregg C, Jeong DK, Jim HSL, Judge AR, Mason TM, Parker N, Pillai S, Qayyum A, Rajasekhara S, Rasool G, Tinsley SM, Schabath MB, Stewart P, West J, McDonald P, Permuth JB. Park MA, et al. Among authors: rasool g. Cancers (Basel). 2024 Jun 27;16(13):2364. doi: 10.3390/cancers16132364. Cancers (Basel). 2024. PMID: 39001427 Free PMC article. Review.
Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma.
Permuth JB, Park MA, Chen DT, Basinski T, Powers BD, Gwede CK, Dezsi KB, Gomez M, Vyas SL, Biachi T, Cortizas EM, Crowder S, Genilo-Delgado M, Green BL, Greene A, Gregg C, Hoffe SE, Jiang K, Kim B, Vasudevan V, Garcialopez De Llano J, Menon AA, Mo Q, MorenoUrazan LM, Mok S, Parker N, Rajasekhara S, Rasool G, Sinnamon A, Sparks L, Stewart PA, Tardif K, Tassielli AF, Teer JK, Tran DV, Turner KL, Vadaparampil ST, Whelan CJ, Douglas WG, Velanovich V, Karachristos A, Legaspi A, Meredith K, Molina-Vega MA, Huguet KL, Arnoletti JP, Bloomston M, Trevino J, Merchant NB, Pimiento JM, Hodul PJ, Malafa M, Fleming J, Judge SM, Jeong DK, Judge A. Permuth JB, et al. Among authors: rasool g. Front Oncol. 2024 Jul 23;14:1362244. doi: 10.3389/fonc.2024.1362244. eCollection 2024. Front Oncol. 2024. PMID: 39109281 Free PMC article.
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancements.
Villanueva-Meyer JE, Bakas S, Tiwari P, Lupo JM, Calabrese E, Davatzikos C, Bi WL, Ismail M, Akbari H, Lohmann P, Booth TC, Wiestler B, Aerts HJWL, Rasool G, Tonn JC, Nowosielski M, Jain R, Colen RR, Pati S, Baid U, Vollmuth P, Macdonald D, Vogelbaum MA, Chang SM, Huang RY, Galldiks N; Response Assessment in Neuro Oncology (RANO) group. Villanueva-Meyer JE, et al. Among authors: rasool g. Lancet Oncol. 2024 Nov;25(11):e581-e588. doi: 10.1016/S1470-2045(24)00316-4. Lancet Oncol. 2024. PMID: 39481414 Review.
Generative Artificial Intelligence in Anatomic Pathology.
Brodsky V, Ullah E, Bychkov A, Song AH, Walk EE, Louis P, Rasool G, Singh RS, Mahmood F, Bui MM, Parwani AV. Brodsky V, et al. Among authors: rasool g. Arch Pathol Lab Med. 2025 Jan 21. doi: 10.5858/arpa.2024-0215-RA. Online ahead of print. Arch Pathol Lab Med. 2025. PMID: 39836377 Free article.
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice.
Bakas S, Vollmuth P, Galldiks N, Booth TC, Aerts HJWL, Bi WL, Wiestler B, Tiwari P, Pati S, Baid U, Calabrese E, Lohmann P, Nowosielski M, Jain R, Colen R, Ismail M, Rasool G, Lupo JM, Akbari H, Tonn JC, Macdonald D, Vogelbaum M, Chang SM, Davatzikos C, Villanueva-Meyer JE, Huang RY; Response Assessment in Neuro Oncology (RANO) group. Bakas S, et al. Among authors: rasool g. Lancet Oncol. 2024 Nov;25(11):e589-e601. doi: 10.1016/S1470-2045(24)00315-2. Lancet Oncol. 2024. PMID: 39481415 Review.
99 results